Pephexia Therapeutics ApS: Financial statements 2022
CVR: 41319208
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pephexia Therapeutics ApS (CVR 41319208) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -5,266,259 and a net result of DKK -6,677,466 compared with DKK -4,532,328 the year before. Equity in the 2022 report amounted to DKK -7,146,211. The company had 3 employees in the financial year.
- Gross Profit
- DKK -5,266,259
- Profit/Loss
- DKK -6,677,466
- Equity
- DKK -7,146,211
- Total Assets
- DKK 9,746,400
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -5.3M | -6.7M | -7.1M | 3 |
| 2021 | 626K | -4.7M | -4.5M | -2.7M | 0 |
Official annual report
Keep an eye on Pephexia Therapeutics ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 16, 2022, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Pephexia Therapeutics ApS.
As of November 22, 2022, Fogtmann Fosgerau Holding ApS is registered as an owner of Pephexia Therapeutics ApS with an ownership share of 50%.
As of July 7, 2022, Keld Fogtmann Fosgerau has joined the board of directors of Pephexia Therapeutics ApS.
As of July 7, 2022, Anders Mørkeberg Hinsby has joined the board of directors of Pephexia Therapeutics ApS.
As of July 6, 2022, Keld Fogtmann Fosgerau has left the board of directors of Pephexia Therapeutics ApS.
Pephexia Therapeutics ApS has published its annual report for 2021. Revenue came to DKK 626,000, and the net result was DKK -4,532,328.
About Pephexia Therapeutics ApS
Pephexia Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Keld Fogtmann Fosgerau. The board consists of Anders Mørkeberg Hinsby (chair), Andrew Justin Stewart Coats, Keld Fogtmann Fosgerau and Mats Peter Blom. The company is owned by Fogtmann Fosgerau Holding ApS and Andrew Justin Stewart Coats. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK -179,735 and a net result of DKK -4,440,533 compared with DKK -5,320,870 the year before. Equity in the 2025 report amounted to DKK -19,747,345.